Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
金口馨复方氯己定含漱液
- Development stage
- Phase 4
- Lead developer
- Chenpai Bond Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
金口馨复方氯己定含漱液 (Jinkouxin Compound Chlorhexidine Mouthwash) is a pharmaceutical oral rinse approved in China for the auxiliary treatment of various oral inflammatory conditions. It is a combination drug containing chlorhexidine gluconate, an antiseptic that disrupts bacterial cell membranes, and metronidazole, an antibiotic effective against anaerobic bacteria. This combination works to reduce bacterial load and inflammation, providing relief and promoting healing for conditions such as gingivitis, pericoronitis, oral mucositis, gingival bleeding, periodontal abscess, and oral mucosal ulcers. It is manufactured by Jiangsu Chenpai Bond Pharmaceutical Co., Ltd.
- Brand names
- 金口馨
- Other names
- 复方氯己定含漱液Jinkouxin Compound Chlorhexidine MouthwashCompound Chlorhexidine Mouthwash
02
Targets
Neuraminidase
Beyond the preview
Go deeper on 金口馨复方氯己定含漱液.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 金口馨复方氯己定含漱液.